POST Online Media Lite Edition
 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (6.14.2021, 10:56am CEST, WHO):   U.S. 11,678    India 80,834    Brazil 78,700    France 3,604    Turkey 6,076    Russia 14,723    The United Kingdom 7,550    Italy 1,722    Argentina 18,057    Columbia 29,998    Germany 1,489    Iran 8,195    Mexico 3,649    Peru 3,003    Indonesia 9,868    South Africa 9,319    The Netherlands 1,265    Chile 7,481    Canada 1,290    Philippines 7,302    Iraq 3,952    Pakistan 1,239    Bangladesh 2,436    Japan 1,409    Malaysia 5,304    Nepal 1,649    United Arab Emirates 1,969    Saudi Arabia 1,017    Ecuador 1,813    Bolivia 2,056    Paraguay 1,963    Tunisia 1,861    Uruguay 2,986    Kuwait 1,512    Guatemala 2,395    Venezuela 1,489    Honduras 1,379    Oman 1,482    Sri Lanka 2,361    Thailand 2,804    Cuba 1,470    Zambia 2,358    Afghanistan 1,597    Mongolia 2,188    Namibia 1,399    Uganda 1,735    China 198    Singapore 13    New Zealand 1    Australia 11    South Korea 399   

U.S. connecting supercomputers produce vaccine against coronavirus

Christian Fernsby ▼ |
The United States has combined the power of supercomputers to produce a vaccine against coronavirus through public-private partnerships,” the U.S. Department of Energy said in a press release.

Article continues below



Topics: U.S.    VACCINE    CORONAVIRUS   

"Launching a consortium of high-performance computers against COVID-19 will provide Corona virus researchers with access to the world's most powerful computing resources, which could accelerate the discovery of scientific discoveries in the fight against the virus," the ministry said.

In addition to the Department of Energy and the White House, IBM has been a co-founder of the consortium.

The ministry also said: "The consortium is currently uniting 16 systems that offer computing potential at levels above 330 Flops."

President Donald Trump thanked Google, Microsoft and Amazon, as well as the Massachusetts Institute of Technology and NASA for joining the consortium. ■

What to read next

3-in-1 vaccine against traveler's diarrhea
Candidate Ebola vaccine still effective when highly diluted
Zika vaccine works in early human trial